about
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutic...
Read More
0.34
-0.02
(-5.56%)
404.4K
XNAS Volume
XNAS 20 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
GT Biopharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..